Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus

Brain Research

Volumn 760, Issue 1-2, 1997, Pages 204-209

  Mayhan, William G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Bradykinin; Brain; Nitric oxide; Nitroglycerin; Oxygen radical; Rat; Superoxide anion

Indexed keywords

ACETYLCHOLINE; BRADYKININ; DRUG VEHICLE; GLYCERYL TRINITRATE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TOPICAL DRUG ADMINISTRATION;

ACETYLCHOLINE; ANIMALS; BASILAR ARTERY; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; VASODILATION; VASODILATOR AGENTS;

EID: 0030741054     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00282-5     Document Type: Article

References (49)

1. Boughton-Smith N.K., Deakin A.M., Whittle B.J.R. Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. Agents Actions. 35 Suppl. C:1992;C3-C9.
2. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1988;1315-1321.
3. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87:1991;432-438.
4. Carrington A.L., Calcutt N.A., Ettlinger C.B., Gustafsson T., Tomlinson D.R. Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur. J. Pharmacol. 237:1993;257-263.
5. Cohen R.A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 87:1993;V67-V76.
6. Corbett J.A., Tilton R.G., Chang K., Hasan K.S., Ido Y., Wang J.L., Sweetland M.A., Lancaster J.R. Jr., Williamson J.R., McDaniel M.L. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
7. Dai F.X., Diederich A., Skopec J., Diederich D. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J. Am. Soc. Nephrol. 4:1993;1327-1336.
8. Dandona P., James I.M., Newbury P.A., Woollard M.L., Beckett A.G. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br. Med. J. 2:1978;325-326.
9. Diederich D., Skopec J., Diederich A., Dai F.X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol. 266:1994;H1153-H1161.
10. Faraci F.M. Role of nitric oxide in regulation of basilar artery tone in vivo. Am. J. Physiol. 259:1990;H1216-H1221.
11. Faraci F.M. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am. J. Physiol. 261:1991;H1038-H1042.
12. Fujii K., Heistad D.D., Faraci F.M. Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the rat basilar artery. Stroke. 23:1992;1494-1498.
13. Fujiwara S., Kassell N.F., Sasaki T., Nakagomi T., Lehman R.M. Selective hemoglobin inhibition of endothelium dependent vasodilation of rabbit basilar artery. J. Neurosurg. 64:1986;445-452.
14. Hattori Y., Kawasaki H., Abe K., Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261:1991;H1086-H1094.
15. Kanamaru K., Waga S., Fujimoto K., Itoh H., Kubo Y. Endothelium-dependent relaxation of human basilar arteries. Stroke. 20:1989;1208-1211.
16. Katusic Z.S., Marshall J.J., Kontos H.A., Vanhoutte P.M. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide. Am. J. Physiol. 257:1989;H1235-H1239.
17. Kitazono T., Faraci F.M., Heistad D.D. L-Arginine restores dilator responses of the basilar artery to acetylcholine during chronic hypertension. Hypertension. 27:1996;893-896.
18. Knudsen G.M., Jakobsen J., Barry D.I., Compton A.M., Tomlinson D.R. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience. 29:1989;773-777.
19. Kontos H.A., Wei E.P., Povlishock J.T., Christman C.W. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ. Res. 55:1984;295-303.
20. Kontos H.A., Wei E.P., Povlishock J.T., Kukreja R.C., Hess M.L. Inhibition by arachidonate of cerebral arteriolar dilation from acetylcholine. Am. J. Physiol. 256:1989;H665-H671.
21. Lai F.M., Cobuzzi A., Shepherd C., Tanikella T., Hoffman A., Cervoni P. Endothelium-dependent basilar and aortic vascular responses in normotensive and coarctation hypertensive rats. Life Sci. 45:1989;607-614.
22. Mayhan W.G. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 256:1989;H621-H625.
23. Mayhan W.G. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am. J. Physiol. 259:1990;H1455-H1462.
24. Mayhan W.G. Responses of the basilar artery to products released by platelets during chronic hypertension. Brain Res. 545:1991;97-102.
25. Mayhan W.G. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res. 580:1992;297-302.
26. Mayhan W.G. Cerebral circulation during diabetes mellitus. Pharmacol. Ther. 57:1993;377-391.
27. Mayhan W.G., Didion S.P., Patel K.P. L-Arginine does not restore dilatation of the basilar artery during diabetes mellitus. J. Cereb. Blood Flow Metab. 16:1996;500-506.
28. Mayhan W.G., Simmons L.K., Sharpe G.M. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260:1991;H319-H326.
29. Nakagomi T., Hongo K., Kassell N.F., Sasaki T., Lehman R.M., Ogawa H., Vollmer D.G., Torner J.C. Pharmacological comparison of endothelium-dependent relaxation in isolated cerebral and extracerebral arteries. J. Neurosurg. 69:1988;580-587.
30. Ohishi K., Carmines P.K. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J. Am. Soc. Nephrol. 5:1995;1559-1566.
31. Pelligrino D.A., Albrecht R.F. Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J. Cereb. Blood Flow Metab. 11:1991;667-677.
32. Pelligrino D.A., Koenig H.M., Wang Q., Albrecht R.F. Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. NeuroReport. 5:1994;417-420.
33. Pelligrino D.A., Miletich D.J., Albrecht R.F. Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats. Am. J. Physiol. 262:1992;E447-E454.
34. Pieper G.M., Langenstroer P., Gross G.J. Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rat. Mol. Cell. Biochem. 122:1993;139-145.
35. Pieper G.M., Mei D.A., Langenstroer P., O'Rourke S.T. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am. J. Physiol. Heart Circ. Physiol. 263:1992;H676-H680.
36. Rosenblum W.I. Hydroxyl radical mediates the endothelium dependent relaxation produced by bradykinin in mouse cerebral arterioles. Circ. Res. 61:1987;601-603.
37. Sobey C.G., Heistad D.D., Faraci F.M. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo. Am. J. Physiol. 271:1996;H126-H132.
38. Soltis E.E., Bohr D.F. Cerebral vascular responsiveness in DOCA hypertensive rats. Am. J. Physiol. 252:1987;H198-H203.
39. Taylor P.D., Wickenden A.D., Mirrlees D.J., Poston L. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin induced diabetes: Effect of treatment with the aldose reductase inhibitor, ponalrestat. Br. J. Pharmac. 111:1994;42-48.
40. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Rad. Biol. Med. 16:1994;383-391.
41. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. Heart Circ. Physiol. 263:1992;H321-H326.
42. Tesfamariam B., Palacino J.J., Weisbrod R.M., Cohen R.A. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J. Cardiovasc. Pharmacol. 21:1993;205-211.
43. Tilton R.G., Chang K., Hasan K.S., Smith S.R., Petrash J.M., Misko T.P., Moore W.M., Currie M.G., Corbett J.A., McDaniel M.L., Williamson J.R. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 42:1993;221-232.
44. 2) synthesis by aortic rings from rats with streptozotocin-induced diabetes. Prostaglandins Leukotrienes Essent. Fatty Acids. 44:1991;233-236.
45. Wei E.P., Christman C.W., Kontos H.A., Povlishock J.T. Effects of oxygen radicals on cerebral arterioles. Am. J. Physiol. 248:1985;H157-H162.
46. Wellman G.C., Bevan J.A. Barium inhibits the endothelium-dependent component of flow but not acetylcholine-induced relaxation in isolated rabbit cerebral arteries. J. Pharmacol. Exp. Ther. 274:1995;47-53.
47. Whalley E.T., Amure Y.O., Lye R.H. Analysis of the mechanism of action of bradykinin on human basilar artery in vitro. Arch. Pharmacol. 335:1987;433-437.
48. Wu J.T. Advanced glycosylation end products: a new disease marker for diabetes and aging. J. Clin. Lab. Anal. 7:1993;252-255.
49. Yang S.T., Mayhan W.G., Faraci F.M., Heistad D.D. Mechanisms of impaired endothelium-dependent cerebral vasodilatation in response to bradykinin in hypertensive rats. Stroke. 22:1991;1177-1182.